Company: BIVIW
Filing Date: 2025-09-25
Form Type: DEF 14A
Source: 0001520138-25-000287
Chunk: 21

Company: BIOVIE INC.
Filing Date: 2025-09-25
Form: DEF 14A
Chunk 21
---
 committees
of the Board of Directors on which they served.

Code of Ethics

We have adopted a code of conduct and ethics meeting the requirements of
Section 406 of the Sarbanes-Oxley Act of 2002. We believe our code of conduct and ethics is reasonably designed to deter wrongdoing
and promote honest and ethical conduct; provide full, fair, accurate, timely and understandable disclosure in public reports; comply with
applicable laws; ensure prompt internal reporting of violations; and provide accountability for adherence to the provisions of the code
of ethic. Our code of ethics is accessible under the “Investors-Governance” section of our website at www.bioviepharma.com.
Disclosure regarding any amendments to, or waivers from, provisions of the code of ethics will be included in a Current Report on Form
8-K that will be filed with the SEC within four business days following the date of the amendment or waiver.

Executive Officers

The following table sets forth certain information regarding our executive
officers and some of our key employees, as of September 22, 2025. For information regarding Cuong Do, our President and Chief Executive
Officer, see “The Nominees” above.

| Name              |     | Age |     | Director Since |     | Position                                           |
| Cuong Do          |     |  59 |     |           2016 |     | President and Chief Executive Officer and Director |
| Joanne Wendy Kim  |     |  70 |     |             -- |     | Chief Financial Officer                            |
| Joseph M. Palumbo |     |  65 |     |             -- |     | Chief Medical Officer                              |

Ms. Joanne Wendy Kim has served as the Company’s Chief Financial
Officer since 2018. Ms. Kim previously served as Chief Financial Officer (“CFO”) for several companies throughout her career,
previously with Landmark Education Enterprises, and prior to that, other public entities in the entertainment and financial services industry
sectors. She provided interim CFO services to various organizations through Group JWK from 2016 to 2018. In her various roles, Ms. Kim
oversaw corporate finance and operational groups, closed eight acquisitions, secured bank financings, developed and implemented new business
strategies, managed risk and implemented new financial policies and procedures. As a CPA professional, she advised on accounting transactions,
SEC reporting matters and other regulatory matters to clients serving as a Director at BDO USA, LLP’s National Office